Genmab — Februar 2013
-
Genmab’s daratumumab has the potential to be a game changer. Activity of the anti-CD38 antibody in myeloma represents a new and complementary mechanism of action, meeting a major unmet medical need. Heavily pre-treated multiple myeloma patients extraordinarily achieved a partial response after short single-agent exposure.
-
Although early stage, the data is sufficiently impressive for J&J and Genmab to communicate an ambitious clinical trial programme this year across a variety of haematological cancers, targeting a market opportunity of c $9bn.
-
Nej, det er bare et hurtigt overblik over Genmab. Intet nyt.
-
-
not found?
-
Det var alligevel for ringe til at have liggende offentligt tilgængeligt på nettet.
-
læg mærke til at det er udlandet der akkumulerer p.t. og de private der sælger
-
InvestABC skriver til mig han fjernede artiklen fra Nordnetbloggen fordi han godt kunne se at den var forfejlet samt at "meningen med investabc ikke er at lave enkeltkald på enkeltaktier"
-
så ikke nok med den var faktuel så forkert, at der nærmest var tale om et fabrikeret indlæg, så er det heller deres koncept? Gud fader bevares.
-
FDA åbner op for hurtigere medicingodkendelser
De amerikanske sundhedsmyndigheder vil indføre nye regler, som vil tillade innovative lægemidler mod alvorlige sygdomme at komme på markedet langt hurtigere end tidligere.
(medwatch.dk)
-
Og hun forklarer, at man allerede har givet den nye break-through status til tre lovende lægemidler.
-
ved vi hvilke 3?
-
dara kan vel ikke være iblandt de,. Det ville være for sindssygt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind